brain

Postbac Poster Day Returns to NIH Campus

Budding Scientists Assemble for First Time Since 2019

IRP postbac fellow Vernon Kennedy with his poster at Postbac Poster Day

In many ways, working at NIH feels like being at a world-renowned university, complete with a variety of classes, intellectually stimulating lectures, social events, and opportunities for professional development. It’s no wonder, then, that NIH has long been a destination for young people who have just departed from their alma maters with their newly earned undergraduate degrees.

These new graduates come to the IRP to hone their scientific skills in NIH’s Postbac IRTA program, conducting research in IRP labs for one or two years under the expert guidance of the IRP’s seasoned investigators. The program also provides the opportunity once per year for participants to present the fruits of their efforts to all their IRP colleagues at Postbac Poster Day, and this year’s event on April 19 and 20 was the first to include an in-person component since 2019. Read on to learn about a few of the nearly 1,000 postbacs who showed off their research at this year’s event, which spanned fields from neuroscience and cancer to genetics and virtual reality.

Symposium Celebrates Award-Winning Female Scientists

Three Young Women Honored at Annual Event

Dr. Brittany Lord

There’s no doubt that science flourishes when it welcomes individuals with different backgrounds and perspectives. In pursuit of that goal, NIH has put considerable effort into closing the gender gap in the biomedical sciences, a field in which men significantly outnumber women, especially as the heads of labs and in leadership positions. Those efforts have so far yielded promising progress, with the proportion of women in IRP senior investigator positions increasing from 22 percent at the end of fiscal year 2016 to 27 percent at the end of fiscal year 2022. Over that same time period, women went from comprising 38 percent of IRP tenure-track investigators to 44 percent.

Part of what makes the IRP a welcoming place for female scientists is the NIH Women Scientists Advisors (WSA), a group of IRP scientists elected to represent the interests of women in the IRP. Once per year, the WSA selects a few female postdoctoral fellows or graduate students conducting research at NIH as WSA Scholars. At a symposium on April 13 honoring the achievements of this year’s Scholars, the awardees presented their efforts to learn more about a devastating childhood neurological condition, decrease health disparities in breast cancer, and use stem cells to investigate the roots of a nerve-destroying disorder. Read on to learn more about this year’s WSA Scholars and the important work they’re doing in their IRP labs.

NIH Mourns the Passing of Dr. Herbert M. Geller

Dr. Herb Geller

The IRP community is saddened by the recent passing of our esteemed colleague, Herb Geller, Ph.D., who died April 16, 2023, at the NIH Clinical Center from complications of advanced prostate cancer. He is survived by his wife of 55 years, Nancy Geller, Ph.D., who is the Director of the Office of Biostatistics Research at the National Heart, Lung, and Blood Institute (NHLBI).

Dr. Geller joined the National Institutes of Health in 2001, where he became the Chief of the Developmental Neurobiology Laboratory in the Cell and Developmental Biology Center at NHLBI. During his long and successful career in neurobiology, Dr. Geller made a significant impact on the field of neuroscience. His laboratory focuses on understanding the role of the extracellular matrix — the intricate network of molecules that surround cells which control migration, pathfinding, and growth of neurons during brain development.

Hunger Hormone Feeds Alcohol Cravings

IRP Researchers Pursue New Approaches to Treating Alcohol Use Disorder

man eating pasta

While most adults in the U.S. consume alcohol in moderation, for nearly 30 million of them, going even one day without alcohol feels nearly impossible. For these Americans, alcohol use disorder (AUD) is a serious condition that harms their health, relationships, and career. Unfortunately, only a small percentage of people with AUD receive treatment, and even then, for many patients, the chances of a relapse are high.

As the search for a reliable and effective treatment continues, IRP senior investigator Lorenzo Leggio, M.D., Ph.D., is exploring the biological processes that underlie alcohol cravings to unlock new approaches to therapy. April is Alcohol Awareness Month, so we took the opportunity to speak with him about recent discoveries made by his IRP team and its collaborators.

Examining the Roots of Opioid Use Disorder

IRP Researchers Are Peering Into the Brain to Learn Why Opioid Drugs Are So Hard to Quit

oxycodone pills and pill bottle

The ancient Egyptians, despite their significant anatomical knowledge, thought the heart was the seat of intelligence. Over the millennia, that view changed as philosophers and scientists alike came to appreciate the extraordinary role of the brain. It is partly thanks to them that we celebrate Brain Awareness Week every March. In honor of this observance, we took the opportunity to talk with IRP senior investigator Yihong Yang, Ph.D., and postdoctoral fellow Ida Fredriksson, Ph.D., Pharm.D., about their investigation into how cravings for opioids build during a period of prolonged abstinence, often leading to relapse.

Moms’ Caffeine Consumption May Affect Babies’ Brains

Findings Could Explain Why Caffeine Exposure In-Utero Increases Kids’ Risk for Obesity

steaming cup of coffee

Between books, the media, and well-meaning friends and relatives, new parents are inundated with advice about how to set their kids up for a happy and healthy future. However, what parents do before their children are even born can also have a huge impact on how they turn out. For instance, new IRP research suggests that a pregnant woman’s caffeine consumption can rewire her baby’s brain in ways that put the child at increased risk for obesity later in life.

IRP Scientist Shares Path From Stuttering to Science

Diversity-Focused NIH Program Helps Dr. Shahriar SheikhBahaei Investigate the Neuroscience of Voluntary Movement

Dr. Shahriar SheikhBahaei

IRP neuroscientist Shahriar SheikhBahaei, Ph.D., first became aware of his stutter when he was 5 years old. Years later, his career would revolve around studying the biological roots of his speech impediment. But before he could start his own lab focused on how the brain controls voluntary movement, he needed a leg up from NIH’s Independent Research Scholars (IRS) program.

Postdoc Profile: Going the Extra Mile

Dr. Ayland Letsinger examines the effects of exercise on the brain

Dr. Ayland Letsinger

Every January, gyms are flooded with new members using the beginning of a new year as a burst of motivation to get fit. When many of these new exercise enthusiasts abandon their new healthy habit within a couple months, they shouldn’t feel guilty, according to IRP postdoctoral fellow Ayland Letsinger, Ph.D. He believes there’s a genetic component behind our fluctuating interest in exercise, and he spends his days in his IRP lab investigating such biological factors behind the motivation to move.

“More people would rather binge-watch 'Stranger Things’ for three hours than do 30 minutes of moderate physical activity, and there may be a biological basis behind it,” he explains.

Combination Therapy Shows Increased Effectiveness Against Brain Cancer

Additional Treatment Cuts off Tumor Cells’ Escape Route From Anti-Cancer Drug

MRI showing glioblastoma tumor in the brain

Despite the many therapies that scientists have created to fight cancer, treating the disease is often still a frustrating game of cat and mouse. Just when doctors think they have managed to defeat their wily opponent, it comes roaring back as strong as ever. A new IRP study suggests a two-pronged approach that relies in part on an existing anti-cancer drug could more effectively thwart a particularly deadly form of brain cancer.

Toxic Protein and Aging Combine Forces to Drive Brain Disease

IRP Study Suggests New Therapeutic Targets for Pair of Age-Related Illnesses

older man

Aging wears down all parts of our bodies, from our bones to our brains. It’s no surprise, then, that it’s the main risk factor for neurological illnesses like Parkinson’s disease and dementia. However, the precise reason why has long remained a mystery. New IRP research suggests that the aged brain is a fertile ground for the spread of a harmful protein associated with several neurological diseases, and that the toxic protein itself ages immune cells in the brain.